Mesa Laboratories Management
Management criteria checks 2/4
Mesa Laboratories' CEO is Gary Owens, appointed in Sep 2017, has a tenure of 7.17 years. total yearly compensation is $5.44M, comprised of 13.9% salary and 86.1% bonuses, including company stock and options. directly owns 0.8% of the company’s shares, worth $4.32M. The average tenure of the management team and the board of directors is 7.2 years and 4.5 years respectively.
Key information
Gary Owens
Chief executive officer
US$5.4m
Total compensation
| CEO salary percentage | 13.9% |
| CEO tenure | 7.2yrs |
| CEO ownership | 0.8% |
| Management average tenure | 7.2yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding
Nov 20
We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt
Oct 17A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb
Jul 29Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?
May 03Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?
Mar 15Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 08Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?
Dec 05Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?
Sep 28Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Aug 09We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt
Jun 28Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking
May 31A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Apr 12Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Mar 13Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Dec 20Mesa Laboratories declares $0.16 dividend
Oct 03Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced
Sep 09Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?
Sep 06Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Aug 08Mesa Laboratories GAAP EPS of -$0.27 misses by $0.27, revenue of $50.45M misses by $1.72M
Aug 04Mesa Laboratories declares $0.16 dividend
Jul 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$246m |
| Jun 30 2024 | n/a | n/a | -US$250m |
| Mar 31 2024 | US$5m | US$754k | -US$254m |
| Dec 31 2023 | n/a | n/a | US$948k |
| Sep 30 2023 | n/a | n/a | -US$717k |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | US$5m | US$733k | US$930k |
| Dec 31 2022 | n/a | n/a | -US$1m |
| Sep 30 2022 | n/a | n/a | -US$4m |
| Jun 30 2022 | n/a | n/a | -US$2m |
| Mar 31 2022 | US$18m | US$579k | US$2m |
| Dec 31 2021 | n/a | n/a | US$8m |
| Sep 30 2021 | n/a | n/a | US$5m |
| Jun 30 2021 | n/a | n/a | US$4m |
| Mar 31 2021 | US$3m | US$524k | US$3m |
| Dec 31 2020 | n/a | n/a | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$2m |
| Jun 30 2020 | n/a | n/a | -US$2m |
| Mar 31 2020 | US$3m | US$600k | US$2m |
| Dec 31 2019 | n/a | n/a | US$5m |
| Sep 30 2019 | n/a | n/a | US$10m |
| Jun 30 2019 | n/a | n/a | US$8m |
| Mar 31 2019 | US$3m | US$520k | US$7m |
| Dec 31 2018 | n/a | n/a | US$10m |
| Sep 30 2018 | n/a | n/a | -US$2m |
| Jun 30 2018 | n/a | n/a | -US$249k |
| Mar 31 2018 | US$1m | US$417k | -US$3m |
Compensation vs Market: Gary's total compensation ($USD5.44M) is above average for companies of similar size in the US market ($USD2.18M).
Compensation vs Earnings: Gary's compensation has increased whilst the company is unprofitable.
CEO
Gary Owens (56 yo)
7.2yrs
Tenure
US$5,435,566
Compensation
Mr. Gary M. Owens has been Chief Executive Officer, President and Director of Mesa Laboratories, Inc. since September 1, 2017. Mr. Owens joined as Chief Operating Officer in March 2017. Mr. Owens served as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 7.2yrs | US$5.44m | 0.80% $ 4.3m | |
| VP, CFO & Chief Accounting Officer | 12.1yrs | US$1.94m | 0.22% $ 1.2m | |
| Senior Vice President of Continuous Improvement | 6.8yrs | US$1.62m | 0% $ 0 |
7.2yrs
Average Tenure
55yo
Average Age
Experienced Management: MLAB's management team is seasoned and experienced (7.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 7.2yrs | US$5.44m | 0.80% $ 4.3m | |
| Lead Independent Director | 3.1yrs | US$220.03k | 0.057% $ 306.7k | |
| Independent Chairman of the Board | 15.7yrs | US$255.13k | 1.34% $ 7.2m | |
| Independent Director | 2.4yrs | US$220.13k | 0.049% $ 267.2k | |
| Independent Director | less than a year | US$90.03k | 0.013% $ 72.2k | |
| Independent Director | 4.5yrs | US$220.13k | 0.051% $ 277.8k | |
| Independent Director | 5.7yrs | US$220.13k | 0.064% $ 346.5k |
4.5yrs
Average Tenure
58yo
Average Age
Experienced Board: MLAB's board of directors are considered experienced (4.5 years average tenure).